US 11352446
Methods of making multispecific antigen-binding molecules
granted A61KA61K2039/505
Quick answer
US patent 11352446 (Methods of making multispecific antigen-binding molecules) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505